View Article

Abstract

For the identification, separation, detection, and quantification of numerous pharmaceuticals and their related degradants, HPLC is a commonly used analytical technique. The proper compatibility and stability of the medication as well as contaminants and degradants depends on the selection of the mobile phase, stationary phase, column, column size, temperature, wavelength, and gradient. The majority of pharmaceuticals and other chemicals may be examined using the HPLC method because of its many benefits, including speed, specificity, accuracy, precision, and ease of automation. This article was written with the intention of reviewing several HPLC-related topics, including its principle, kinds, manner of separation, characteristics, instrumentation, key parameters, and numerous applications in various sectors.

Keywords

New Changes, Type Information.

Introduction

High-performance liquid chromatography (or High strain liquid chromatography, HPLC) is a precise shape of column chromatography normally used in biochemistry and evaluation to separate, identify, and quantify the lively compounds.[1] HPLC ordinarily makes use of a column that holds packing cloth (stationary phase), a pump that strikes the cell phase(s) thru the column, and a detector that indicates the retention instances of the molecules. Retention time varies relying on the interactions between the stationary phase, the molecules being analyzed, and the solvent(s) used.

[2]pattern to be analyzed is added in small quantity to the flow of cell segment and is retarded with the aid of unique chemical or bodily interactions with the stationary phase. The quantity of retardation relies upon on the nature of the analyte and composition of each stationary and cellular phase. The time at which a precise analyte elutes (comes out of the quit of the column) is known as the retention time. [3] High Performance Liquid Chromatography which is additionally regarded as High Pressure Liquid Chromatography. It is a famous analytical method used for the separation, identification and quantification of each constituent of mixture. HPLC is an superior approach of column liquid chromatography. The solvent commonly flows thru column with the assist of gravity however in HPLC method the solvent will be pressured beneath excessive pressures upto four hundred atmospheres so that pattern can be separated into special materials with the assist of distinction in relative affinities.[4-10] Pumps are used in HPLC to move pressurised liquid solvent and the sample mixture into a column that is packed with solid adsorbent material. Each sample component will interact differently, which results in different flow rates for each component and, ultimately, leads to the separation of column components. Adsorption is a component of the mass exchange process that makes up chromatography. Pumps are used in HPLC to pressurized a fluid and a sample blend through an adsorbent-filled section, causing the specimen segments to separate. Adsorbent, the section’s dynamic segment, is often a granular substance comprised of solid particles with sizes ranging from 2 m to 50 m, such as silica and polymers. The different degrees of connectivity between the segments of the example mixture/blend and the retentive particles isolate them from one another. The’mobile phase’, which is the pressured fluid, is

HISTORY AND BACKGROUND OF HPLC

High-Performance Liquid Chromatography (HPLC) emerged as a pivotal analytical technique in the 20th century, evolving from earlier chromatography methods. Its history reflects advancements in instrumentation, materials, and applications across chemistry, biology, and industry.

Early Foundations (1900s–1950s)

Chromatography Origins: The concept of chromatography began with Mikhail Tswett in 1903, who used liquid chromatography to separate plant pigments. His work laid the groundwork for separating compounds based on their interaction with a stationary phase and a mobile phase. Partition and Paper Chromatography: In the 1940s, Archer J.P. Martin and Richard L.M. Synge developed partition chromatography, earning them the 1952 Nobel Prize in Chemistry. Their work introduced liquid-liquid partitioning, a precursor to modern HPLC. Paper chromatography also gained traction during this period for simple separations. Gas Chromatography Influence: The development of gas chromatography in the 1950s by James and Martin highlighted the need for high-resolution liquid-based techniques, spurring interest in advancing liquid chromatography.

Birth of HPLC (1960s)

Theoretical Advances: In the early 1960s, researchers like Calvin Giddings and Josef Huber emphasized the need for high-pressure systems to achieve faster, more efficient liquid chromatography. Giddings’ 1965 book, Dynamics of Chromatography, provided theoretical insights into optimizing column efficiency.

Applications: By the 1970s, HPLC was widely adopted in pharmaceuticals for drug analysis, in food science for quality control, and in biochemistry for protein and peptide separations.

Refinement and Specialization (1980s–1990s)

Smaller Particles and Columns: The 1980s saw the use of 3–5 µm particles, enhancing resolution and speed. Narrow-bore and microbore columns reduced solvent consumption and improved sensitivity. Automation and Data Systems: Computer-controlled systems and automated injectors streamlined workflows. Software for data acquisition and analysis, like Waters’ Empower, became integral.

Chiral Separations: The development of chiral stationary phases enabled enantiomer separations, critical for pharmaceutical development.

Mass Spectrometry Coupling: The 1990s marked the rise of HPLC-MS (mass spectrometry), combining HPLC’s separation power with MS’s identification capabilities. Electrospray ionization (ESI) facilitated analysis of large biomolecules.

UPLC Precursor: The push for faster analyses led to the development of sub-2 µm particles and higher-pressure systems, setting the stage for Ultra-Performance Liquid Chromatography (UPLC).

Importance of HPLC

High-Performance Liquid Chromatography (HPLC) is a critical analytical technique with widespread importance across various fields due to its precision, versatility, and ability to separate, identify, and quantify components in complex mixtures. Here's a concise overview of its significance:

Pharmaceutical Industry:

Ensures drug purity, quality, and safety by analyzing raw materials, intermediates, and final products. Supports drug development through pharmacokinetic studies and stability testing. Detects impurities and degradation products at trace levels.

Environmental Analysis:

Monitors pollutants like pesticides, heavy metals, and organic compounds in water, soil, and air. Ensures compliance with environmental regulations by detecting contaminants at low concentrations.

Food Safety and Quality:

Analyzes food for additives, preservatives, vitamins, and contaminants like mycotoxins or pesticide residues. Ensures nutritional content and authenticity (e.g., detecting adulteration in olive oil or honey). Clinical and Biomedical Research: Quantifies biomarkers, drugs, and metabolites in biological samples (e.g., blood, urine) for diagnostics and therapeutic monitoring. Supports research in proteomics, metabolomics, and toxicology. Forensic Science: Identifies drugs, toxins, or poisons in forensic samples. Provides accurate evidence for legal investigations through trace analysis. Chemical and Material Science: Characterizes polymers, surfactants, and other complex mixtures. Supports quality control in chemical manufacturing.

High Sensitivity and Versatility:

Separates compounds with high resolution, even in complex matrices. Adaptable to various sample types (liquid, solid, or gas-dissolved) and detection methods (UV, fluorescence, mass spectrometry).

Regulatory Compliance:

Widely accepted in industries for meeting stringent regulatory standards (e.g., FDA, EPA, USP). Provides reproducible and reliable data for validation and documentation.

TYPE OF HPLC

NORMAL-PHASE HPLC:

Uses a polar stationary phase (e.g., silica gel) and a non-polar mobile phase (e.g., hexane). This method is suitable for separating less polar or non-polar compounds.

Reverse-phase HPLC:

Uses a non-polar stationary phase (e.g., C18) and a polar mobile phase (e.g., water and an organic solvent). It's widely used for separating polar and moderately polar compounds.

Ion-exchange chromatography:

Separates analytes based on their charge using a stationary phase with charged sites.

Size-exclusion chromatography (SEC):

Separates molecules based on their size and molecular weight.

Affinity chromatography:

Separates analytes based on their specific binding to a ligand immobilized on the stationary phase.

Chiral chromatography:

Separates enantiomers (mirror image isomers) using a chiral stationary phase.

Hydrophilic interaction chromatography (HILIC):

Separates molecules based on their interaction with a thin layer of water on the stationary phase.

PARAMETERS

SYSTEM SUITABILITY PARAMETERS

The system suitability parameters which are generally accepted by regulatory authorities and independent auditor are depicted below:

Peak retention time, Peak area,

Amount, Peak height,

Peak width at half height, Peak symmetry,

Peak tailing, Capacity factor (k?), Plate numbers,

Resolution between peaks, Selectivity relative to preceding peak Peak symmetry and tailing factor [8]

Our treatment of chromatography in this section assumes that a solute elutes as a symmetrical Gaussian peak, such as that shown in Figure 1 as dotted line. This ideal behaviour occurs when the solute?s partition coefficient, KD is the same for all concentrations of solute

NEW CHANGES OF HPLC

Retention models

The variety of chromatographic systems available, and the wide range of solutes that are separated using these systems, makes the choice of a suitable starting point for model development somewhat of a search for the famous needle in a haystack , as a wide range of strategies are available (see Figure 1). A number of commercial simulation software tools are available [7], such as DryLab by Molnar-Institute [12 ], AutoChrome [13] by ACD/Labs (replacing ChromGenius after 2018), and Auto

Transport models

Since tracking all the solute molecules in (HP)LC is neither feasible nor necessary, continuum approaches in terms of solute concentrations are used. Transport models typically use spatial or temporal averaged solute and solvent concentrations in the mobile and stationary phases. The uniform and dense packing within an HPLC column suggests model reduction to the axial ( ) dimension (see Figure 2a). This can be an oversimplification for preparative or process chromatography, where the larger.

Monitoring and control In the previous section, we discussed how various modelling approaches can be employed to analyse, model and design chromatographic processes. However, a number of factors, such as imperfect column packing, the presence of disturbances, plant-model mismatch and so on, can hinder optimal operation of the real plant and product quality specifications might therefore be violated. Adequate process control is often required, which can either be conventional (i.e. P, PI, PID controllers) or advanced

The ideal characteristics

  • Adequate sensitivity for the particular task.
  • Good stability and reproducibility.
  • The wide linear dynamic range of response.
  • Short response time that is independent of flow rate.
  • Insensitive to changes in a solvent, flow rate, and temperature.
  • Cell design that eliminates remixing of the separated bands.
  • High reliability and ease of use.
  • Non-destructive for the sample.

CONCLUSION

HPLC method is important to separate and quantify the main drug and any reaction impurities. In HPLC, the mobile phase is a liquid. Reversed-phase HPLC is the most common type of HPLC. What reversed-phase means is that the mobile phase is relatively polar, and the stationary phase is relatively non-polar. Therefore, the non- polar compounds will be more retained (i.e. have longer retention times) than a polar compound. In normal phase HPLC, the mobile phase is relatively non-polar and the stationary phase is relatively polar. These components are separated from one another by the column packing that involves various chemical and/or physical interactions between their molecules and the packing particles. These separated components are detected at the exit of a column by a flow-through device (detector) that measures their amount. Output from this detector is called an “HPLC” in principle, LC and HPLC work the same way except for the speed, efficiency, sensitivity, and ease of operation of HPLC are vastly superior. It is also the most accurate analytical method widely used for the quantitative as well as qualitative analysis of drug.

REFERENCES

        1. Gerber F, Krummen M, Potgeter H, Roth A, Siffrin C, Spoendlin C. Practical aspects of fast reversed-phase high-performance liquid chromatography using 3 microm particle packed columns and monolithic columns in pharmaceutical development and production working under current good manufacturing practice. J Chromatogr A. 2004 May 21;1036(2):127-33. doi: 10.1016/j.chroma.2004.02.056. PMID: 15146913.
        2. Xiang Y, Liu Y, Lee ML. Ultrahigh pressure liquid chromatography using elevated temperature. J Chromatogr A. 2006 Feb 3;1104(1-2):198-202. doi: 10.1016/j.chroma.2005.11.118. PMID: 16376355.
        3. Bergh JJ, Breytenbach JC. Stability-indicating high-performance liquid chromatographic analysis of trimethoprim in pharmaceuticals. J Chromatogr. 1987 Jan 30;387:528-31. doi: 10.1016/s0021- 9673(01)94565-0. PMID: 3558640.
        4. Haginaka J, Yasuda H, Uno T, Nkagawa T. Alkaline degradation and determination by high- performance by high-performance liquid chromatography. Chemical Pharmacy. Bullet. 1984; 32: 2752-2758
        5. Fredj G, Paillet M, Aussel F, Brouard A, Barreteau H, Divine C, Micaud M. Determination of sulbactam in biological fluids by high-performance liquid chromatography. J Chromatogr. 1986 Nov 28;383(1):218-22. doi: 10.1016/s0378-4347(00)83464-7. PMID: 3029153.
        6. Ayrton J. Assay of ceftazidime in biological fluids using high-pressure liquid chromatography. J Antimicrob Chemother. 1981 Sep;8 Suppl B:227-31. doi: 10.1093/jac/8.suppl_b.227. PMID: 19802990.
        7. Polite L. Liquid chromatography: basic overview. In: Miller J, Crowther JB [eds], Analytical chemistry in a GMP environment: a practical guide. John wiley & sons, New York. 2000.
        8. United States Pharmacopoeia. 27th ed. The USP Convention Inc., Rockville, MD. 2014.
        9. Rodenas V, Garcia MS, Sanchez-Pedreno C, Albero MI. Flow-injection spectrophotometric determination of frusemide or sulphathiazole in pharmaceuticals.                     Journal of Pharmacy and Biomedical Analyst. 1997; 15: 1687-1693.
        10. Chemical Analysis Modern Instrumentation Methods and Techniques, Second Edition, Francis Rouessac and Annick Rouessac, University of Le Mans, France.
        11.  Abidi SL. High-performance liquid chromatography of phosphatidic acids and related polar lipids. Journal of Chromatography. 1991; 587: 193-203.
        12. The European Pharmacopoeia. fourth ed., Council of Europe, Strasbourg. 2002.
        13.  Tsai IL, Weng TI, Tseng YJ, Tan HK, Sun HJ, Kuo CH. Screening and confirmation of 62 drugs of abuse and metabolites in urine by ultra-high-performance liquid chromatography-quadrupole time-of- flight mass spectrometry. J Anal Toxicol. 2013 Nov-Dec;37(9):642-51. doi: 10.1093/jat/bkt083. Epub 2013 Sep 30. PMID: 24084874.
        14. Hearn MTW. Ion-pair chromatography on normal and reversed-phase systems. Advance Chromatography. 1980; 18: 59–100.
        15. Siddiqui MR, AlOthman ZA, Rahman N. Analytical techniques in pharmaceutical analysis: A review. Arabian Journal of Chemistry. 2013.
        16.  Willard H, Merritt L, Dean J, Settle F. Instrumental Methods of Analysis, 7th edn, Wadsworth Publishers, Stamford, CT. 1998
        17. Chromatographia 19, 145 (1984)T.M. Zimina, R.M. Smith, P. Myers, B.W. King, Chromatographia 40, 662 (1995)S.M. Han, D.W. Armstrong, Anal. Chem. 59, 1583 (1987)R.T. Kennedy, J.W. Jorgenson,
        18. Anal. Chem. 61, 1128 (1989)S. Hsieh, J.W. Jorgenson, Anal. Chem. 68, 1212 (1996)E.C. Huang, T. Wachs, J.J. Conboy, J.D. Henion, Anal. Chem. 62, 713A (1990)P.R. Brown, Anal. Chem. 62, 995A
        19. (1990)C.L. Flurer, C. Borra, F. Andreolini, M. Novotny, J. Chromatogr. A 448, 73 (1988)S. Van der Wal,  F.J.  Yang,  J.  High  Resolut.  Chromatogr. 6, 216 (1983) N.  Nagae,  H.  Itoh,  N.  Nimura,  T.
        20. Kinoshita, T. Takeuchi, J. Microcol. Sep. 3, 5 (1991)H.A. Claessens, A. Burcinova, C.A. Cramers, P. Mussche, C.C. E. van Tilburg, J. Microcol. Sep. 2, 132 (1990)J.W. Jorgenson, E.J. Guthrie, J. Chromatog
        21. A 255, 335 (1983)A. Manz, W. Simon, J. Chromatogr. A 387, 187 (1987)R.C. Simpson, J. Chromatogr.
        22. A 691, 163 (1995)G. Kamperman, J.C. Kraak, J. Chromatogr. B 337, 384 (1985)M.J. Mills, J. Maltas, W.J. Lough, J. Chromatogr. A 759, 1 (1997)H.J. Tarigan, P. Neill, C.K. Kenmore, D.J. Bornhop, Anal. Chem. 68,
        23. 1762 (1996)A.E. Bruno, B. Krattiger, F. Maystre, H.M. Widmer, Anal. Chem. 63, 2689 (1991)M. Jane?ek, V. Kahle, M. Krej?i, J. Chromatogr. A 438, 409 (1988)J.P. Chervet,                                   M. Ursem, J.P. Salzmann, R.W. Vannoort, J. High Resolut. Chromatogr. 12, 278 (1989)P. Sandra, G. Steenbeke, M. Ghys, G.
        24. Schomburg, J. High Resolut. Chromatogr. 13, 527 (1990) M.   Verzele,          G. Steenbeke,                               J.  Vindevogel, J. Chromatogr. A 477, 87 (1989)T. Takeuchi, D. Ishii, J. High Resolut. Chromatogr. 7, 151 (1984)T. Takeuchi, D. Ishii, Chromatographia           25, 697 (1988) E.J. Guthrie, J.W. Jorgenson, Anal. Chem. 56, 483 (1984)A.G. Ewing, J.M. Mesaros, P.F. Gavin, Anal.

Reference

        1. Gerber F, Krummen M, Potgeter H, Roth A, Siffrin C, Spoendlin C. Practical aspects of fast reversed-phase high-performance liquid chromatography using 3 microm particle packed columns and monolithic columns in pharmaceutical development and production working under current good manufacturing practice. J Chromatogr A. 2004 May 21;1036(2):127-33. doi: 10.1016/j.chroma.2004.02.056. PMID: 15146913.
        2. Xiang Y, Liu Y, Lee ML. Ultrahigh pressure liquid chromatography using elevated temperature. J Chromatogr A. 2006 Feb 3;1104(1-2):198-202. doi: 10.1016/j.chroma.2005.11.118. PMID: 16376355.
        3. Bergh JJ, Breytenbach JC. Stability-indicating high-performance liquid chromatographic analysis of trimethoprim in pharmaceuticals. J Chromatogr. 1987 Jan 30;387:528-31. doi: 10.1016/s0021- 9673(01)94565-0. PMID: 3558640.
        4. Haginaka J, Yasuda H, Uno T, Nkagawa T. Alkaline degradation and determination by high- performance by high-performance liquid chromatography. Chemical Pharmacy. Bullet. 1984; 32: 2752-2758
        5. Fredj G, Paillet M, Aussel F, Brouard A, Barreteau H, Divine C, Micaud M. Determination of sulbactam in biological fluids by high-performance liquid chromatography. J Chromatogr. 1986 Nov 28;383(1):218-22. doi: 10.1016/s0378-4347(00)83464-7. PMID: 3029153.
        6. Ayrton J. Assay of ceftazidime in biological fluids using high-pressure liquid chromatography. J Antimicrob Chemother. 1981 Sep;8 Suppl B:227-31. doi: 10.1093/jac/8.suppl_b.227. PMID: 19802990.
        7. Polite L. Liquid chromatography: basic overview. In: Miller J, Crowther JB [eds], Analytical chemistry in a GMP environment: a practical guide. John wiley & sons, New York. 2000.
        8. United States Pharmacopoeia. 27th ed. The USP Convention Inc., Rockville, MD. 2014.
        9. Rodenas V, Garcia MS, Sanchez-Pedreno C, Albero MI. Flow-injection spectrophotometric determination of frusemide or sulphathiazole in pharmaceuticals.                     Journal of Pharmacy and Biomedical Analyst. 1997; 15: 1687-1693.
        10. Chemical Analysis Modern Instrumentation Methods and Techniques, Second Edition, Francis Rouessac and Annick Rouessac, University of Le Mans, France.
        11.  Abidi SL. High-performance liquid chromatography of phosphatidic acids and related polar lipids. Journal of Chromatography. 1991; 587: 193-203.
        12. The European Pharmacopoeia. fourth ed., Council of Europe, Strasbourg. 2002.
        13.  Tsai IL, Weng TI, Tseng YJ, Tan HK, Sun HJ, Kuo CH. Screening and confirmation of 62 drugs of abuse and metabolites in urine by ultra-high-performance liquid chromatography-quadrupole time-of- flight mass spectrometry. J Anal Toxicol. 2013 Nov-Dec;37(9):642-51. doi: 10.1093/jat/bkt083. Epub 2013 Sep 30. PMID: 24084874.
        14. Hearn MTW. Ion-pair chromatography on normal and reversed-phase systems. Advance Chromatography. 1980; 18: 59–100.
        15. Siddiqui MR, AlOthman ZA, Rahman N. Analytical techniques in pharmaceutical analysis: A review. Arabian Journal of Chemistry. 2013.
        16.  Willard H, Merritt L, Dean J, Settle F. Instrumental Methods of Analysis, 7th edn, Wadsworth Publishers, Stamford, CT. 1998
        17. Chromatographia 19, 145 (1984)T.M. Zimina, R.M. Smith, P. Myers, B.W. King, Chromatographia 40, 662 (1995)S.M. Han, D.W. Armstrong, Anal. Chem. 59, 1583 (1987)R.T. Kennedy, J.W. Jorgenson,
        18. Anal. Chem. 61, 1128 (1989)S. Hsieh, J.W. Jorgenson, Anal. Chem. 68, 1212 (1996)E.C. Huang, T. Wachs, J.J. Conboy, J.D. Henion, Anal. Chem. 62, 713A (1990)P.R. Brown, Anal. Chem. 62, 995A
        19. (1990)C.L. Flurer, C. Borra, F. Andreolini, M. Novotny, J. Chromatogr. A 448, 73 (1988)S. Van der Wal,  F.J.  Yang,  J.  High  Resolut.  Chromatogr. 6, 216 (1983) N.  Nagae,  H.  Itoh,  N.  Nimura,  T.
        20. Kinoshita, T. Takeuchi, J. Microcol. Sep. 3, 5 (1991)H.A. Claessens, A. Burcinova, C.A. Cramers, P. Mussche, C.C. E. van Tilburg, J. Microcol. Sep. 2, 132 (1990)J.W. Jorgenson, E.J. Guthrie, J. Chromatog
        21. A 255, 335 (1983)A. Manz, W. Simon, J. Chromatogr. A 387, 187 (1987)R.C. Simpson, J. Chromatogr.
        22. A 691, 163 (1995)G. Kamperman, J.C. Kraak, J. Chromatogr. B 337, 384 (1985)M.J. Mills, J. Maltas, W.J. Lough, J. Chromatogr. A 759, 1 (1997)H.J. Tarigan, P. Neill, C.K. Kenmore, D.J. Bornhop, Anal. Chem. 68,
        23. 1762 (1996)A.E. Bruno, B. Krattiger, F. Maystre, H.M. Widmer, Anal. Chem. 63, 2689 (1991)M. Jane?ek, V. Kahle, M. Krej?i, J. Chromatogr. A 438, 409 (1988)J.P. Chervet,                                   M. Ursem, J.P. Salzmann, R.W. Vannoort, J. High Resolut. Chromatogr. 12, 278 (1989)P. Sandra, G. Steenbeke, M. Ghys, G.
        24. Schomburg, J. High Resolut. Chromatogr. 13, 527 (1990) M.   Verzele,          G. Steenbeke,                               J.  Vindevogel, J. Chromatogr. A 477, 87 (1989)T. Takeuchi, D. Ishii, J. High Resolut. Chromatogr. 7, 151 (1984)T. Takeuchi, D. Ishii, Chromatographia           25, 697 (1988) E.J. Guthrie, J.W. Jorgenson, Anal. Chem. 56, 483 (1984)A.G. Ewing, J.M. Mesaros, P.F. Gavin, Anal.

Photo
Nandini choudhary
Corresponding author

SAGE University Bhopal

Photo
Dr. Sarika Shrivastava
Co-author

SAGE University Bhopal

Photo
Dr. Jitendra Banweer
Co-author

SAGE University Bhopal

Nandini Choudhary*, Dr. Sarika Shrivastava, Dr. Jitendra Banweer, HPLC New Changes, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 5, 1976-1982. https://doi.org/10.5281/zenodo.15388596

More related articles
The Role and Impact of Digital-Only Health Interve...
Surbhi Mishra , Dr. Jitendra banweer, Dr. Praveen tahilani , Dr. ...
National Health Program...
Devendra jatav , wati khare, Dr. Jitendra Banweer , ...
Antimicrobial Resistance: Impacts, Challenges, and...
Akshat Markam, Swati Khare, Dr. Jitendra Banweer, ...
LAF (Laminar Air Flow) Manage Particle Size...
Anand Vishwakarma , Dr. Swati Khare, Dr. Jitendra Banweer , ...
LAF (Laminar Air Flow) Manage Particle Size...
Anand Vishwakarma , Dr. Swati Khare, Dr. Jitendra Banweer , ...
The Role and Impact of Digital-Only Health Interventions in the Workplace...
Surbhi Mishra , Dr. Jitendra banweer, Dr. Praveen tahilani , Dr. Sarika Shrivastava , ...
Related Articles
Adverse Drug Reaction Monitoring ...
Ashish kumar , Abhishek Shrivastava , Dr. Jitendra Banweer, ...
Impact of Telemedicine on patient Compliance and Drug Adherence ...
Deepak Sahu , Dr. Praveen Tahilani , Dr. Jitendra Banweer, Dr. Sarika Shrivastava , ...
The Role and Impact of Digital-Only Health Interventions in the Workplace...
Surbhi Mishra , Dr. Jitendra banweer, Dr. Praveen tahilani , Dr. Sarika Shrivastava , ...
More related articles
The Role and Impact of Digital-Only Health Interventions in the Workplace...
Surbhi Mishra , Dr. Jitendra banweer, Dr. Praveen tahilani , Dr. Sarika Shrivastava , ...
National Health Program...
Devendra jatav , wati khare, Dr. Jitendra Banweer , ...
Antimicrobial Resistance: Impacts, Challenges, and Future Prospects...
Akshat Markam, Swati Khare, Dr. Jitendra Banweer, ...
The Role and Impact of Digital-Only Health Interventions in the Workplace...
Surbhi Mishra , Dr. Jitendra banweer, Dr. Praveen tahilani , Dr. Sarika Shrivastava , ...
National Health Program...
Devendra jatav , wati khare, Dr. Jitendra Banweer , ...
Antimicrobial Resistance: Impacts, Challenges, and Future Prospects...
Akshat Markam, Swati Khare, Dr. Jitendra Banweer, ...